02514nam 2200589Ia 450 991082617720332120240516122631.01-60805-007-6(CKB)2670000000066678(EBL)864193(OCoLC)708569306(SSID)ssj0000671906(PQKBManifestationID)11404971(PQKBTitleCode)TC0000671906(PQKBWorkID)10625182(PQKB)10055500(MiAaPQ)EBC864193(Au-PeEL)EBL864193(CaPaEBR)ebr10447986(EXLCZ)99267000000006667820080523d2010 uy 0engur|n|---|||||txtccrAngiogenesis & therapeutic targets in cancer /editor, Malay Chatterjee ; co-editors, Ajay Rana, Basabi Rana1st ed.[S.l.] Bentham e Books[2010]1 online resource (viii, 225 pages)Description based upon print version of record.1-60805-573-6 Includes bibliographical references and index.01 Title.pdf; 02 Cover Page and Dedication; 03 eBooks End User License Agreement-Website; 05 Foreword; 06 Preface; 08 CONTRIBUTORS; 09 Chapter 01; 10 Chapter 02; 11 Chapter 03; 12 Chapter 04; 13 Chapter 05; 14 Chapter 06; 15 Chapter 07; 16 Chapter 08; 17 Chapter 09; 18 Chapter 10; 19 Chapter 11; 21 Chapter 13; 22 INDEX_final_3Angiogenesis plays rate limiting roles in tumor growth and invasion. Angiogenesis inhibition has been proposed as a general strategy to fight against cancers. This book covers different therapeutic targets for angiogenesis interventions with emphasis on clinical development of antiangiogenic drugs that target antiangiogenic cascade in different forms of cancers like breast cancer, multiple myeloma, renal carcinoma, gastrointestinal, prostate and lung cancer.Neovascularization inhibitorsCancerTreatmentAngiogenesis InhibitorsNeovascularization inhibitors.CancerTreatment.Angiogenesis Inhibitors.600Chatterjee MalayRana AjayRana BasabiMiAaPQMiAaPQMiAaPQBOOK9910826177203321Angiogenesis & therapeutic targets in cancer4016866UNINA